Today: 20 May 2026
Browse Category

TSXV:LEM 7 October 2025

Leading Edge Materials (0V3V.L) Surges Amid EU Critical Minerals Boom – Latest News, Stock Trends & Outlook

Leading Edge Materials (0V3V.L) Surges Amid EU Critical Minerals Boom – Latest News, Stock Trends & Outlook

Leading Edge Materials shares surged 27% on Oct. 6, 2025, closing near C$0.30 amid investor interest in its European critical mineral projects. The company recently submitted final data for a 25-year mining lease at its Norra Kärr rare earth site in Sweden, with a decision expected in Q4. It remains pre-revenue, reporting a C$0.61 million net loss last quarter and holding C$0.68 million in working capital before a recent C$2.84 million financing.
7 October 2025
···

Stock Market Today

  • SpaceX IPO Filing Could Propel Elon Musk to Trillionaire Status
    May 20, 2026, 5:46 PM EDT. SpaceX's recent S-1 filing signals a potential initial public offering (IPO) that could surpass the 2020 record set by Saudi Aramco as the largest IPO in history. The deal is expected to significantly increase the valuation of SpaceX, potentially making CEO Elon Musk a trillionaire. This move highlights the growing investor interest in private spaceflight companies and the expanding market for space exploration-related ventures.

Latest articles

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

20 May 2026
Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
Go toTop